SCHEMBL460298

SCHEMBL460298

C=CCC1(CC=C)c2c[c]ccc2-c2cc[c]cc21

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2301308 0.93
SCHEMBL1723731 0.92 PGR (0.40) PGR
SCHEMBL6270695 0.86
SCHEMBL5168856 0.81
SCHEMBL2843199 0.78
SCHEMBL6271793 0.75
SCHEMBL2407953 0.74
SCHEMBL2942957 0.72 PGR (0.41) PGR
SCHEMBL88451 0.71 PGR (0.49) PGR
SCHEMBL30511096 0.71 PGR (0.49) PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3592737-B1 CROSS-LINKABLE ORGANOMETALLIC LIGHT EMITTING COMPLEXES LOMOX LTD (GB) 2022-12-21 EP claimed
US-11316118-B2 Dibenzo[d,B]silole-based reactive mesogens LOMOX LIMITED (GB) 2022-04-26 US claimed
EP-3523313-B1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS LOMOX LTD (GB) 2021-05-05 EP claimed
US-20190280223-A1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS LOMOX LIMITED (GB) 2019-09-12 US claimed
EP-3523313-A1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS Lomox Limited (GB) 2019-08-14 EP claimed
WO-2018162880-A1 CROSS-LINKABLE ORGANOMETALLIC LIGHT EMITTING LIGANDS AND COMPLEXES LOMOX LIMITED (GB) 2018-09-13 WO claimed
WO-2018065786-A1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS LOMOX LIMITED (GB) 2018-04-12 WO claimed
US-7951874-B2 Non-conjugated polymeric perarylated boranes, use thereof as organically semiconductor transmitters and/or transport materials, methods for producing same and uses thereof OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2011-05-31 US claimed
US-20060229431-A1 Non-conjugated polymeric perarylated boranes, use thereof as organically semiconductor transmitters and/or transport materials, methods for producing same and uses thereof OSRAM OLED GMBH (DE) 2006-10-12 US claimed
WO-2006060294-A2 BLUE EMISSIVE OLED MATERIALS KELLY STEPHEN M (GB) 2006-06-08 WO claimed
EP-1439590-A2 Mono-, oligo- and poly-bis(thienyl) arylenes and their use as charge transport materials MERCK PATENT GmbH (DE) 2004-07-21 EP claimed
US-20040119049-A1 Mono-, oligo- and poly-bis(thienyl) arylenes and their use as charge transport materials MERCK PATENT GMBH (DE) 2004-06-24 US claimed
WO-2023136136-A1 COMPOUND AND COLORED RESIN COMPOSITION 住友化学株式会社 2023-07-20 WO disclosed
EP-3592737-B1 CROSS-LINKABLE ORGANOMETALLIC LIGHT EMITTING COMPLEXES LOMOX LTD (GB) 2022-12-21 EP disclosed
US-11316118-B2 Dibenzo[d,B]silole-based reactive mesogens LOMOX LIMITED (GB) 2022-04-26 US disclosed
EP-3523313-B1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS LOMOX LTD (GB) 2021-05-05 EP disclosed
EP-1149827-B1 End-capped polyfluorenes, films and devices based thereon SONY INT EUROPE GMBH (DE) 2003-12-10 EP disclosed
US-20020173617-A1 End-capped polyfluorenes, films and devices based thereon SONY DEUTSCHLAND GMBH (DE) 2002-11-21 US disclosed
WO-2001081294-A1 END-CAPPED POLYFLUORENES, FILMS AND DEVICES BASED THEREON SONY INTERNATIONAL (EUROPE) GMBH (DE) 2001-11-01 WO disclosed
EP-1149827-A1 End-capped polyfluorenes, films and devices based thereon Sony International (Europe) GmbH (DE) 2001-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190280223-A1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS CCNB1, CCNE2, UBE2G2 PGR 1587/4885
US-11316118-B2 Dibenzo[d,B]silole-based reactive mesogens CCNB1, CCNE2, UBE2G2 PGR 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.